Back to Search Start Over

Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status - 13 U.S. Jurisdictions, April 4-July 17, 2021.

Authors :
Scobie HM
Johnson AG
Suthar AB
Severson R
Alden NB
Balter S
Bertolino D
Blythe D
Brady S
Cadwell B
Cheng I
Davidson S
Delgadillo J
Devinney K
Duchin J
Duwell M
Fisher R
Fleischauer A
Grant A
Griffin J
Haddix M
Hand J
Hanson M
Hawkins E
Herlihy RK
Hicks L
Holtzman C
Hoskins M
Hyun J
Kaur R
Kay M
Kidrowski H
Kim C
Komatsu K
Kugeler K
Lewis M
Lyons BC
Lyons S
Lynfield R
McCaffrey K
McMullen C
Milroy L
Meyer S
Nolen L
Patel MR
Pogosjans S
Reese HE
Saupe A
Sell J
Sokol T
Sosin D
Stanislawski E
Stevens K
Vest H
White K
Wilson E
MacNeil A
Ritchey MD
Silk BJ
Source :
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2021 Sep 17; Vol. 70 (37), pp. 1284-1290. Date of Electronic Publication: 2021 Sep 17.
Publication Year :
2021

Abstract

COVID-19 vaccine breakthrough infection surveillance helps monitor trends in disease incidence and severe outcomes in fully vaccinated persons, including the impact of the highly transmissible B.1.617.2 (Delta) variant of SARS-CoV-2, the virus that causes COVID-19. Reported COVID-19 cases, hospitalizations, and deaths occurring among persons aged ≥18 years during April 4-July 17, 2021, were analyzed by vaccination status across 13 U.S. jurisdictions that routinely linked case surveillance and immunization registry data. Averaged weekly, age-standardized incidence rate ratios (IRRs) for cases among persons who were not fully vaccinated compared with those among fully vaccinated persons decreased from 11.1 (95% confidence interval [CI] = 7.8-15.8) to 4.6 (95% CI = 2.5-8.5) between two periods when prevalence of the Delta variant was lower (<50% of sequenced isolates; April 4-June 19) and higher (≥50%; June 20-July 17), and IRRs for hospitalizations and deaths decreased between the same two periods, from 13.3 (95% CI = 11.3-15.6) to 10.4 (95% CI = 8.1-13.3) and from 16.6 (95% CI = 13.5-20.4) to 11.3 (95% CI = 9.1-13.9). Findings were consistent with a potential decline in vaccine protection against confirmed SARS-CoV-2 infection and continued strong protection against COVID-19-associated hospitalization and death. Getting vaccinated protects against severe illness from COVID-19, including the Delta variant, and monitoring COVID-19 incidence by vaccination status might provide early signals of changes in vaccine-related protection that can be confirmed through well-controlled vaccine effectiveness (VE) studies.<br />Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Janelle Delgadillo reports grant support from the Utah Department of Health. Ruth Lynfield reports that she is president of the Council of State and Territorial Epidemiologists, Secretary of the National Foundation for Infectious Diseases, and Associate Editor of the American Academy of Pediatrics Red Book (the fee for which is donated to the Minnesota Department of Health). Rachel K. Herlihy reports funding from the Council of State and Territorial Epidemiologists for travel to meetings and conferences. No other potential conflicts of interest were disclosed.

Details

Language :
English
ISSN :
1545-861X
Volume :
70
Issue :
37
Database :
MEDLINE
Journal :
MMWR. Morbidity and mortality weekly report
Publication Type :
Academic Journal
Accession number :
34529637
Full Text :
https://doi.org/10.15585/mmwr.mm7037e1